| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/11/2004 | CA2392997A1 Prion protein conversion assay, prion protein intermediate and uses thereof |
| 01/11/2004 | CA2392980A1 Electrochemical test strip having a plurality of reaction chambers and methods for using the same |
| 01/08/2004 | WO2004003820A2 System, method, device, and computer program product for extraction, gathering, manipulation, and analysis of peak data from an automated sequencer |
| 01/08/2004 | WO2004003817A1 Mutational profiles in hiv-1 protease correlated with phenotypic drug resistance |
| 01/08/2004 | WO2004003683A2 Conformational sampling by self-organization |
| 01/08/2004 | WO2004003595A1 Method of soil geochemistry analysis prospecting |
| 01/08/2004 | WO2004003568A1 Hematology reference control |
| 01/08/2004 | WO2004003567A1 Diagnostics and therapeutics for diseases associated with the g2a-receptor (g2a) |
| 01/08/2004 | WO2004003566A1 Method of diagnosing changes in the intestinal absorptive surface in an individual |
| 01/08/2004 | WO2004003565A2 A screening method and compounds for treating friedreich ataxia |
| 01/08/2004 | WO2004003563A2 Diagnostic and therapeutic use of ensadin-0581 gene and protein for neurodegenerative diseases |
| 01/08/2004 | WO2004003562A2 Oncolytic viruses as phenotyping agents for neoplasms |
| 01/08/2004 | WO2004003561A1 Peptide rod amphiphiles and self-assembly of same |
| 01/08/2004 | WO2004003560A1 Enhanced diffraction-based biosensor devices |
| 01/08/2004 | WO2004003559A1 Assay device for liquid sample |
| 01/08/2004 | WO2004003558A1 Nano-sized optical fluorescence labels and uses thereof |
| 01/08/2004 | WO2004003557A1 Assay for detecting an analyte containing or labelled with a haem moiety |
| 01/08/2004 | WO2004003556A1 Electrochemical detection method and device |
| 01/08/2004 | WO2004003555A1 Method for determination of likelihood of occurrence of preterm labor in pregnant females |
| 01/08/2004 | WO2004003554A1 A method for the detection of apoptosis |
| 01/08/2004 | WO2004003552A1 Method for producing probe carrier, apparatus for producing the same and method for quality assurance therefor |
| 01/08/2004 | WO2004003550A2 Individualization of therapy with anticoagulants |
| 01/08/2004 | WO2004003549A2 Automatic differentiation of a sample solution and a control solution |
| 01/08/2004 | WO2004003548A1 Method for the determination of characteristics and/or the classification of circulating macrophages, and analysis arrangement for carrying out said method |
| 01/08/2004 | WO2004003547A1 A soil moisture sampling device and method |
| 01/08/2004 | WO2004003546A1 Method and device for spectrophotometric analysis |
| 01/08/2004 | WO2004003545A1 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |
| 01/08/2004 | WO2004003544A1 Methods and compositions for the diagnosis and treatment of demyelinating inflammatory disorders |
| 01/08/2004 | WO2004003539A1 Method of analyzing substance on substrate by mass spectrometry |
| 01/08/2004 | WO2004003538A2 Multi-electrode device for detecting an analyte |
| 01/08/2004 | WO2004003535A1 Planar nanowire based sensor elements, devices, systems and methods for using and making same |
| 01/08/2004 | WO2004003533A1 Gas analyzer for measuring the flammability of mixtures of combustible gases and oxygen |
| 01/08/2004 | WO2004003516A1 Method, device and system for detecting the presence of microorganisms |
| 01/08/2004 | WO2004003513A2 Compositions and methods for determining the replication capacity of a pathogenic virus |
| 01/08/2004 | WO2004003512A2 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 01/08/2004 | WO2004003511A2 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 01/08/2004 | WO2004003510A2 Fluorescent dyes, energy transfer couples and methods |
| 01/08/2004 | WO2004003509A2 A method to identify specific interaction between ligand and receptor |
| 01/08/2004 | WO2004003508A2 Magnetic nanomaterials and methods for detection of biological materials |
| 01/08/2004 | WO2004003507A2 Methods for identifying regulators of muscle mass using amylin receptors |
| 01/08/2004 | WO2004003505A2 Methods for detecting and inactivating a prion |
| 01/08/2004 | WO2004003493A2 Methods and kits for determining energy expenditure in living organisms by metabolic water production |
| 01/08/2004 | WO2004003343A1 System for detecting gas in a wellbore during drilling |
| 01/08/2004 | WO2004003234A2 A system and method for snp genotype clustering |
| 01/08/2004 | WO2004003233A1 Methods to assess quality of microarrays |
| 01/08/2004 | WO2004003231A2 Remanent magnetic paricles capable of binding a target substance, their production and uses thereof |
| 01/08/2004 | WO2004003226A1 Enzyme-based monitoring device for the thermal processing of objects |
| 01/08/2004 | WO2004003225A1 Method for high throughput screening of plant growth regulator |
| 01/08/2004 | WO2004003224A1 Electrochemical sensing using an enzyme electrode |
| 01/08/2004 | WO2004003223A2 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 01/08/2004 | WO2004003221A2 Methods for peptide-protein binding prediction |
| 01/08/2004 | WO2004003202A1 Modified par receptors, their preparation and their uses for selecting compounds which modulate par activity |
| 01/08/2004 | WO2004003198A1 Method of examining allergic disease and drug for treating the same |
| 01/08/2004 | WO2004003179A1 Differentiation modulating agents and uses therefor |
| 01/08/2004 | WO2004003176A2 Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs |
| 01/08/2004 | WO2004003168A2 Clustering biological data using mutual information |
| 01/08/2004 | WO2004003166A2 Antibodies and uses thereof |
| 01/08/2004 | WO2004003156A2 Il-21 as a regulator of immunoglobin production |
| 01/08/2004 | WO2004003132A2 Methods and systems of biomolecular sequence matching |
| 01/08/2004 | WO2004003020A1 Method of detecting perilymphatic fistula |
| 01/08/2004 | WO2004003003A1 Methods for identifying cancer risk |
| 01/08/2004 | WO2004002996A1 Ferrocene compound and use thereof |
| 01/08/2004 | WO2004002995A1 Phosphoramidites for coupling oligonucleotides to [2 + 2] photoreactive groups |
| 01/08/2004 | WO2004002950A1 Sulfenyl compound, labeling reagent, and method of analyzing peptide |
| 01/08/2004 | WO2004002518A1 Prevention, therapy and prognosis/monitoring in sepsis and septic shock |
| 01/08/2004 | WO2004002516A1 Diagnostics/preventives/re medies for respiratory diseases |
| 01/08/2004 | WO2004002515A1 Diagnostics/preventives/remedies for respiratory diseases |
| 01/08/2004 | WO2004002513A2 Proteins involved in the regulation of energy homeostasis |
| 01/08/2004 | WO2004002497A1 Glycoalkaloid compositions and various uses thereof |
| 01/08/2004 | WO2004002413A2 In vivo angiogenesis assay |
| 01/08/2004 | WO2004002400A2 A method for screening a candidate substance as a potential drug for the treatment of malaria |
| 01/08/2004 | WO2004002308A2 Management of gastro-intestinal disorders |
| 01/08/2004 | WO2004002307A2 Management of gastro-intestinal disorders |
| 01/08/2004 | WO2004002296A2 Therapeutic methods for reducing fat deposition and treating associated conditions |
| 01/08/2004 | WO2003097857A3 Method for the detection of aquaretic compounds |
| 01/08/2004 | WO2003095969A3 Sample collection device comprising a hydrophilic membrane for separating particulate material in the sample |
| 01/08/2004 | WO2003091408A3 Characterization of single stranded nucleic acids by melting analysis using a double strand specific nucleic acid dye |
| 01/08/2004 | WO2003090666A3 Glucocorticoid receptor protein crystals |
| 01/08/2004 | WO2003090665A3 Regulation of erythrocyte apoptosis |
| 01/08/2004 | WO2003087397A3 Process control based on microbiological activity |
| 01/08/2004 | WO2003086233A3 Thermal monitoring of tissue perfusion with recalibration. |
| 01/08/2004 | WO2003085127A3 Method for identification of insulin receptor kinase activators |
| 01/08/2004 | WO2003085090A3 A human ribonucleotide reductase m2 subunit |
| 01/08/2004 | WO2003083488A3 Method for identifying stat affecting agents |
| 01/08/2004 | WO2003083438A3 Methods and systems for molecular modeling |
| 01/08/2004 | WO2003083130A3 Detection of malaria parasites by mass spectrometry |
| 01/08/2004 | WO2003083044A3 Tissue analogs for in vitro testing and method of use therefor |
| 01/08/2004 | WO2003078959A3 Methods for shp1 mediated neuroprotection |
| 01/08/2004 | WO2003076949A3 Tagging and recovery of elements associated with target molecules |
| 01/08/2004 | WO2003074059A3 Materials and methods relating to the treatment of lymphoma |
| 01/08/2004 | WO2003073818A3 Proteomic analysis of tumors for development of consultative report of therapeutic options |
| 01/08/2004 | WO2003073106A3 Binding of pathological forms of prion proteins |
| 01/08/2004 | WO2003070316A3 Arrangement for receiving electrical signals from living cells and for stimulation |
| 01/08/2004 | WO2003069332A3 Detection and/or monitoring of synuclein-related diseases |
| 01/08/2004 | WO2003068928A3 Gene function inferring using gene expression data |
| 01/08/2004 | WO2003068150A3 Methods of treating and diagnosing arthritis |
| 01/08/2004 | WO2003067262A3 Methods and compositions involving the hsp90 activator aha1 |
| 01/08/2004 | WO2003062829A3 Identifying chemotherapeutic compounds |
| 01/08/2004 | WO2003062828A3 Determining chemotherapeutic effectiveness |
| 01/08/2004 | WO2003060478A3 Methods and compositions for assaying homocysteine |